Immunotherapeutic strategies to induce inflection in the immune response: therapy for cancer and COVID-19

References

• Abbas, A.K., Lichtman, A.H., & Pillai, S. (2017). Properties and overview of immune responses. In Cellular and Molecular Immunology Vol. 2017. 9th (pp. 1–11). Elsevier.
   Google Scholar
• Alatrash, G., Jakher, H., Stafford, P. D., & Mittendorf, E. A. (2013). Cancer immunotherapies, their safety and toxicity. Expert Opinion on Drug Safety, 12(5), 631–645. https://doi.org/10.1517/14740338.2013.795944
   PubMed Web of Science ®Google Scholar
• Alcami, A. (2003). Viral mimicry of cytokines, chemokines and their receptors. Nature Reviews Immunology, 3(1), 36–50. https://doi.org/10.1038/nri980
   PubMed Web of Science ®Google Scholar
• Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S., Korets, L., Lam, J., Tawfik, D., DeNardo, D. G., Naldini, L., de Visser, K. E., De Palma, M., & Coussens, L. M. (2010). FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer cell, 17(2), 121–134. https://doi.org/10.1016/j.ccr.2009.12.019
   PubMed Web of Science ®Google Scholar
• Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., Schuster, S. J., Millenson, M. M., Cattry, D., Freeman, G. J., Rodig, S. J., Chapuy, B., Ligon, A. H., Zhu, L., Grosso, J. F., Kim, S. Y., Timmerman, J. M., Shipp, M. A., & Armand, P. (2015). PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. The New England Journal of Medicine, 372(4), 311–319. https://doi.org/10.1056/NEJMoa1411087
   PubMed Web of Science ®Google Scholar
• Asherson, R.A., Gunter, K., Daya, D., & Shoenfeld, Y. (2014). Multiple autoimmune diseases in a young woman: Tuberculosis and splenectomy as possible triggering factors? Another example of the “mosaic” of autoimmunity. The Journal of Rheumatology, 35(6). https://pubmed.ncbi.nlm.nih.gov/18528954/
   Google Scholar
• Bascones-Martinez, A., Mattila, R., Gomez-Font, R., & Meurman, J. H. (2014). Immunomodulatory drugs: Oral and systemic adverse effects. Medicina oral, patologia oral y cirugia bucal, 19(1), e24–31. https://doi.org/10.4317/medoral.19087
   PubMed Web of Science ®Google Scholar
• Bendib, I., Beldi-Ferchiou, A., Schlemmer, F., Surenaud, M., Maitre, B., Plonquet, A., Carteaux, G., Razazi, K., Godot, V., Hüe, S., Mekontso Dessap, A., & de Prost, N. (2021). Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS. Critical care, 25(1), 23. London, England. https://doi.org/10.1186/s13054-020-03427-y
   PubMed Web of Science ®Google Scholar
• Benzie, I.F.F., & Wachtel-Galor, S. (2011). Editors.Turmeric, the golden spice: From traditional medicine to modern medicine herbal medicine: Biomolecular and clinical aspects (2nd ed.). CRC Press/Taylor & Francis. https://www.ncbi.nlm.nih.gov/books/NBK92752/
   Google Scholar
• Bix, M., Liao, N. S., Zijlstra, M., Loring, J., Jaenisch, R., & Raulet, D. (1991). Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature, 349(6307), 329–331. https://doi.org/10.1038/349329a0
   PubMed Web of Science ®Google Scholar
• Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A., & Wherry, E. J. (2009). Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nature Immunology, 10(1), 29–37. https://doi.org/10.1038/ni.1679
   PubMed Web of Science ®Google Scholar
• Bloch, E. M., Shoham, S., Casadevall, A., Sachais, B. S., Shaz, B., Winters, J. L., van Buskirk, C., Grossman, B. J., Joyner, M., Henderson, J. P., Pekosz, A., Lau, B., Wesolowski, A., Katz, L., Shan, H., Auwaerter, P. G., Thomas, D., Sullivan, D. J., Paneth, N. … Tobian, A. A. (2020). Deployment of convalescent plasma for the prevention and treatment of COVID-19. The Journal of Clinical Investigation, 130(6), 2757–2765. https://doi.org/10.1172/JCI138745
   PubMed Web of Science ®Google Scholar
• Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., & Abbate, A. (2021). Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nature Reviews Immunology, 21(5), 319–329. https://doi.org/10.1038/s41577-021-00536-9
   PubMed Web of Science ®Google Scholar
• Bottcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis E Sousa, C. (2018). NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell, 172(5), 1022–1037.e14. https://doi.org/10.1016/j.cell.2018.01.004
   PubMed Web of Science ®Google Scholar
• Bradford, K., & Shih, D. Q. (2011). Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease. World Journal of Gastroenterology, 17(37), 4166–4173. https://doi.org/10.3748/wjg.v17.i37.4166
   PubMed Web of Science ®Google Scholar
• Brodin, P., & Davis, M. M. (2017). Human immune system variation. Nature Reviews Immunology, 17(1), 21–29. https://doi.org/10.1038/nri.2016.125
   PubMed Web of Science ®Google Scholar
• BURNET, M. (1957). Cancer: A biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. British Medical Journal, 1(5023), 841–847. https://doi.org/10.1136/bmj.1.5023.841
   PubMed Web of Science ®Google Scholar
• Burnet, F. M. (1970). The concept of immunological surveillance. Progress in Experimental Tumor Research, 13, 1–27. https://doi.org/10.1159/000386035
   PubMed Web of Science ®Google Scholar
• Burns, E. A., Muhsen, I. N., Anand, K., Xu, J., Umoru, G., Arain, A. N., & Abdelrahim, M. (2021). Hepatitis B virus reactivation in cancer patients treated with immune checkpoint inhibitors. Journal of Immunotherapy, 44(3), 132–139. Hagerstown, Md. : 1997. https://doi.org/10.1097/CJI.0000000000000358
   PubMed Web of Science ®Google Scholar
• Cable, J., Greenbaum, B., Pe’Er, D., Bollard, C. M., Bruni, S., Griffin, M. E., Allison, J. P., Wu, C. J., Subudhi, S. K., Mardis, E. R., Brentjens, R., Sosman, J. A., Cemerski, S., Zavitsanou, A. M., Proia, T., Egeblad, M., Nolan, G., Goswami, S., Spranger, S., & Mackall, C. L. (2021). Frontiers in cancer immunotherapy—a symposium report. Annals of the New York Academy of Sciences, 1489(1), 30–47. https://doi.org/10.1111/nyas.14526
   PubMed Web of Science ®Google Scholar
• Carsons, S. E. (2008). Issues related to clinical trials of oral and biologic disease-modifying agents for Sjögren’s syndrome. Rheumatic Diseases Clinics of North America, 34(4), 1011. https://doi.org/10.1016/j.rdc.2008.08.005
   PubMed Web of Science ®Google Scholar
• Catanzaro, M., Corsini, E., Rosini, M., Racchi, M., & Lanni, C. (2018). Immunomodulators inspired by nature: A review on curcumin and echinacea. Molecules, 23(11), 2778. Basel, Switzerland. https://doi.org/10.3390/molecules23112778
   PubMed Web of Science ®Google Scholar
• Cerwenka, A., & Lanier, L. L. (2016). Natural killer cell memory in infection, inflammation and cancer. Nature Reviews Immunology, 16(2), 112–123. https://doi.org/10.1038/nri.2015.9
   PubMed Web of Science ®Google Scholar
• CG, D. (2012). Combination immunotherapy approaches. Annals of Oncology, 23(Supplement 8), viii41–46. 2012. https://doi.org/10.1093/annonc/mds262
   PubMed Web of Science ®Google Scholar
• Challis, G. B., & Stam, H. J. (1990). The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta oncologica, 29(5), 545–550. Stockholm, Sweden. https://doi.org/10.3109/02841869009090048
   PubMed Web of Science ®Google Scholar
• Chan, L. S. (2012). Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid). Clinics in Dermatology, 30(1), 34–37. https://doi.org/10.1016/j.clindermatol.2011.03.007
   PubMed Web of Science ®Google Scholar
• Chang, S. H., Mirabolfathinejad, S. G., Katta, H., Cumpian, A. M., Gong, L., Caetano, M. S., Moghaddam, S. J., & Dong, C. (2014). T helper 17 cells play a critical pathogenic role in lung cancer. Proceedings of the National Academy of Sciences of the United States of America, 111(15), 5664–5669. https://doi.org/10.1073/pnas.1319051111
   PubMed Web of Science ®Google Scholar
• Chaudhary, H., Rawat, A., & Singh, S. (2020). Does Genetics Play a Role in Auto-immune Diseases?. In S. Sharma (Ed.), Women's Health in Autoimmune Diseases. Singapore: Springer. https://doi.org/10.1007/978-981-15-0114-2_1
   Google Scholar
• Cheng, A., & Mann, C. (2006). Oral erosive lichen planus treated with efalizumab. Archives of Dermatology, 142(6), 680–682. https://doi.org/10.1001/archderm.142.6.680
   PubMedGoogle Scholar
• Chen, L., & Han, X. (2015). Anti-PD-1/PD-L1 therapy of human cancer: Past, present, and future. The Journal of Clinical Investigation, 125(9), 3384–3391. https://doi.org/10.1172/JCI80011
   PubMed Web of Science ®Google Scholar
• Chen, D. S., & Mellman, I. (2017). Elements of cancer immunity and the cancer-immune set point. Nature, 541(7637), 321–330. https://doi.org/10.1038/nature21349
   PubMed Web of Science ®Google Scholar
• Chida, K., Nakanishi, K., Shomura, H., Homma, S., Hattori, A., Kazui, K., & Taketomi, A. (2017). Spontaneous regression of transverse colon cancer: A case report. Surgical case reports, 3(1), 65. https://doi.org/10.1186/s40792-017-0341-z
   PubMedGoogle Scholar
• Chiriva-Internati, M., & Bot, A. (2015). A new era in cancer immunotherapy: Discovering novel targets and reprogramming the immune system. International Reviews of Immunology, 34(2), 101–103. https://doi.org/10.3109/08830185.2015.1015888
   PubMed Web of Science ®Google Scholar
• Coffelt, S. B., & de Visser, K. E. (2015). Immune-mediated mechanisms influencing the efficacy of anticancer therapies. Trends in Immunology, 36(4), 198–216. https://doi.org/10.1016/j.it.2015.02.006
   PubMed Web of Science ®Google Scholar
• Das, R., Bar, N., Ferreira, M., Newman, A. M., Zhang, L., Bailur, J. K., Bacchiocchi, A., Kluger, H., Wei, W., Halaban, R., Sznol, M., Dhodapkar, M. V., & Dhodapkar, K. M. (2018). Early B cell changes predict autoimmunity following combination immune checkpoint blockade. The Journal of Clinical Investigation, 128(2), 715–720. https://doi.org/10.1172/JCI96798
   PubMed Web of Science ®Google Scholar
• DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., Rugo, H. S., Hwang, E. S., Jirström, K., West, B. L., & Coussens, L. M. (2011). Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discovery, 1(1), 54–67. https://doi.org/10.1158/2159-8274.CD-10-0028
   PubMed Web of Science ®Google Scholar
• Deng, X., Shao, Z., & Zhao, Y. (2021). Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy. Advanced Science, 8(3), 2002504. https://doi.org/10.1002/advs.202002504
   Web of Science ®Google Scholar
• D’Errico, G., Machado, H. L., & Sainz, B., Jr. (2017). A current perspective on cancer immune therapy: Step-by-step approach to constructing the magic bullet. Clinical and Translational Medicine, 6(1), 3. https://doi.org/10.1186/s40169-016-0130-5
   PubMed Web of Science ®Google Scholar
• Dominguez-Soto, A., Sierra-Filardi, E., Puig-Kröger, A., Pérez-Maceda, B., Gómez-Aguado, F., Corcuera, M. T., Sánchez-Mateos, P., & Corbí, A. L. (2011). Dendritic Cell-Specific ICAM-3–grabbing Nonintegrin Expression on M2-Polarized and Tumor-Associated Macrophages is Macrophage-CSF Dependent and Enhanced by Tumor-Derived IL-6 and IL-10. The Journal of Immunology, 186(4), 2192–2200. Baltimore, Md. : 1950. https://doi.org/10.4049/jimmunol.1000475
   PubMed Web of Science ®Google Scholar
• Donadon, M., Hudspeth, K., Cimino, M., DiTommaso, L., Preti, M., Tentorio, P., Roncalli, M., Mavilio, D., & Torzilli, G. (2017). Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 21(8), 1226–1236. https://doi.org/10.1007/s11605-017-3446-6
   PubMed Web of Science ®Google Scholar
• Donskov, F. (2013). Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Seminars in Cancer Biology, 23(3), 200–207. https://doi.org/10.1016/j.semcancer.2013.02.001
   PubMed Web of Science ®Google Scholar
• Esfahani, K., Elkrief, A., Calabrese, C., Lapointe, R., Hudson, M., Routy, B., Miller, W. H., Jr., & Calabrese, L. (2020). Moving towards personalized treatments of immune-related adverse events. Nature Reviews Clinical Oncology, 17(8), 504–515. https://doi.org/10.1038/s41571-020-0352-8
   PubMed Web of Science ®Google Scholar
• Ferguson, F. M., & Gray, N. S. (2018). Kinase inhibitors: The road ahead. Nature Reviews Drug Discovery, 17(5), 353–377. https://doi.org/10.1038/nrd.2018.21
   PubMed Web of Science ®Google Scholar
• Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359–386. https://doi.org/10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Fife, B. T., & Bluestone, J. A. (2008). Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunological reviews, 224(1), 166–182. https://doi.org/10.1111/j.1600-065X.2008.00662.x
   PubMed Web of Science ®Google Scholar
• Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J., & Moser, M. (1994). Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. European Journal of Immunology, 24(3), 605–610. https://doi.org/10.1002/eji.1830240317
   PubMed Web of Science ®Google Scholar
• Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009). Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer cell, 16(3), 183–194. https://doi.org/10.1016/j.ccr.2009.06.017
   PubMed Web of Science ®Google Scholar
• Gong, L., Cumpian, A. M., Caetano, M. S., Ochoa, C. E., De la Garza, M. M., Lapid, D. J., Mirabolfathinejad, S. G., Dickey, B. F., Zhou, Q., & Moghaddam, S. J. (2013). Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase. Molecular cancer, 12(1), 154. https://doi.org/10.1186/1476-4598-12-154
   PubMed Web of Science ®Google Scholar
• Gonzalez, H., Robles, I., & Werb, Z. (2018). Innate and acquired immune surveillance in the postdissemination phase of metastasis. The FEBS Journal, 285(4), 654–664. https://doi.org/10.1111/febs.14325
   PubMed Web of Science ®Google Scholar
• Gottlieb, R. L., Nirula, A., Chen, P., Boscia, J., Heller, B., Morris, J., Huhn, G., Cardona, J., Mocherla, B., Stosor, V., Shawa, I., Kumar, P., Adams, A. C., Van Naarden, J., Custer, K. L., Durante, M., Oakley, G., Schade, A. E., Holzer, T. R. … Skovronsky, D. M. (2021). Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial. JAMA, 325(7), 632–644. https://doi.org/10.1001/jama.2021.0202
   PubMed Web of Science ®Google Scholar
• Grady, D. Harnessing the immune system to fight cancer. The New York Times. Jul 30, 2016. https://www.nytimes.com/2016/07/31/health/harnessing-the-immune-system-to-fight-cancer.html
   Google Scholar
• Guo, C., Manjili, M. H., Subjeck, J. R., Sarkar, D., Fisher, P. B., & Wang, X. Y. (2013). Therapeutic cancer vaccines: Past, present, and future. Advances in Cancer Research, 119, 421–475. https://doi.org/10.1016/B978-0-12-407190-2.00007-1
   PubMed Web of Science ®Google Scholar
• Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674. https://doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Hasan, S. (2020). An overview of promising biomarkers in cancer screening and detection. Current Cancer Drug Targets, 20(11), 831–852. https://doi.org/10.2174/1568009620666200824102418
   PubMed Web of Science ®Google Scholar
• He, Y., Rivard, C. J., Rozeboom, L., Yu, H., Ellison, K., Kowalewski, A., Zhou, C., & Hirsch, F. R. (2016). Lymphocyte-activation gene-3, an important immune checkpoint in cancer. Cancer science, 107(9), 1193–1197. https://doi.org/10.1111/cas.12986
   PubMed Web of Science ®Google Scholar
• Hodi, F. S., O’Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., Akerley, W., van den Eertwegh, A. J., Lutzky, J., Lorigan, P., Vaubel, J. M., Linette, G. P., Hogg, D., Ottensmeier, C. H., Lebbé, C. … Urba, W. J. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. The New England Journal of Medicine, 363(8), 711–723. https://doi.org/10.1056/NEJMoa1003466
   PubMed Web of Science ®Google Scholar
• Horby, P.W., Mafham, M., Peto, L., Campbell, M., Pessoa-Amorim, G., Spata, E., Staplin, N., Emberson, J.R., Prudon, B., Hine, P., Brown, T., Green, C.A., Sarkar, R., Desai, P., Yates, B., Bewick, T., Tiberi, S., Felton, T., Baillie, J.K., Buch, M.H., Chappell, L.C. et al . (2021). Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. https://doi.org/10.1101/2021.06.15.21258542
   Google Scholar
• Hosseini, H., Obradović, M., Hoffmann, M., Harper, K. L., Sosa, M. S., Werner-Klein, M., Nanduri, L. K., Werno, C., Ehrl, C., Maneck, M., Patwary, N., Haunschild, G., Gužvić, M., Reimelt, C., Grauvogl, M., Eichner, N., Weber, F., Hartkopf, A. D., Taran, F. A. … Klein, C. A. (2016). Early dissemination seeds metastasis in breast cancer. Nature, 540(7634), 552–558. https://doi.org/10.1038/nature20785
   PubMed Web of Science ®Google Scholar
• Hossen, M. J., Jeon, S. H., Kim, S. C., Kim, J. H., Jeong, D., Sung, N. Y., Yang, S., Baek, K. S., Kim, J. H., Yoon, D. H., Song, W. O., Yoon, K. D., Cho, S. H., Lee, S., Kim, J. H., & Cho, J. Y. (2015). In vitro and in vivo anti-inflammatory activity of Phyllanthus acidus methanolic extract. Journal of Ethnopharmacology, 168, 217–228. https://doi.org/10.1016/j.jep.2015.03.043
   PubMed Web of Science ®Google Scholar
• Houghton, A. M., Rzymkiewicz, D. M., Ji, H., Gregory, A. D., Egea, E. E., Metz, H. E., Stolz, D. B., Land, S. R., Marconcini, L. A., Kliment, C. R., Jenkins, K. M., Beaulieu, K. A., Mouded, M., Frank, S. J., Wong, K. K., & Shapiro, S. D. (2010). Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nature medicine, 16(2), 219–223. https://doi.org/10.1038/nm.2084
   PubMed Web of Science ®Google Scholar
• Huang, C. T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L., Ravi, S., Kowalski, J., Levitsky, H. I., Powell, J. D., Pardoll, D. M., Drake, C. G., & Vignali, D. A. (2004). Role of LAG-3 in regulatory T cells. Immunity, 21(4), 503–513. https://doi.org/10.1016/j.immuni.2004.08.010
   PubMed Web of Science ®Google Scholar
• Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013). P53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. The Journal of Experimental Medicine, 210(10), 2057–2069. https://doi.org/10.1084/jem.20130783
   PubMed Web of Science ®Google Scholar
• Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Che, X., Iwashige, H., Aridome, K., Hokita, S., & Aikou, T. (2000). Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer, 88(3), 577–583. doi:10.1002/(SICI)1097-0142(20000201)88:3<577:AID-CNCR13>3.0.CO;2-V
   PubMed Web of Science ®Google Scholar
• Iwama, S., De Remigis, A., Callahan, M. K., Slovin, S. F., Wolchok, J. D., & Caturegli, P. (2014). Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Science Translational Medicine, 6(230), 230ra45. https://doi.org/10.1126/scitranslmed.3008002
   PubMed Web of Science ®Google Scholar
• Jacobs, C. F., Eldering, E., & Kater, A. P. (2021). Kinase inhibitors developed for treatment of hematologic malignancies: Implications for immune modulation in COVID-19. Blood Advances, 5(3), 913–925. https://doi.org/10.1182/bloodadvances.2020003768
   PubMed Web of Science ®Google Scholar
• Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., Becker, J. R., Slosky, D. A., Phillips, E. J., Pilkinton, M. A., Craig-Owens, L., Kola, N., Plautz, G., Reshef, D. S., Deutsch, J. S. … Moslehi, J. J. (2016). Fulminant myocarditis with combination immune checkpoint blockade. The New England Journal of Medicine, 375(18), 1749–1755. https://doi.org/10.1056/NEJMoa1609214
   PubMed Web of Science ®Google Scholar
• Jose, J., Sudhakaran, S., Sumesh Kumar, T. M., Jayaraman, S., & Jayadevi Variyar, E. (2014). Study of in vitro immunomodulatory effect of flavonoid isolated from Phyllanthus niruri on human blood lymphocytes and evaluation of its antioxidant potential. International Journal of Pharmacognosy and Phytochemical Research international Journal of Pharmacognosy and Phytochemical Research, 6(2), 284–289. 1. https://ijppr.openresearchjournals.com/index.php/ijppr/article/view/416
   Google Scholar
• June, C. H., Warshauer, J. T., & Bluestone, J. A. (2017). Corrigendum: Is autoimmunity the Achilles’ heel of cancer immunotherapy? Nature medicine, 23(8), 1004. https://doi.org/10.1038/nm0817-1004b
   PubMed Web of Science ®Google Scholar
• Jung, S. M., Akhmetzhanov, A. R., Hayashi, K., Linton, N. M., Yang, Y., Yuan, B., Kobayashi, T., Kinoshita, R., & Nishiura, H. (2020). Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: Inference using exported cases. Journal of Clinical Medicine, 9(2), 523. https://doi.org/10.3390/jcm9020523
   PubMed Web of Science ®Google Scholar
• Karlhofer, F. M., Ribaudo, R. K., & Yokoyama, W. M. (1992). MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature, 358(6381), 66–70. https://doi.org/10.1038/358066a0
   PubMed Web of Science ®Google Scholar
• Karlitepe, A., Ozalp, O., & Avci, C. B. (2015). New approaches for cancer immunotherapy. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine, 36(6), 4075–4078. https://doi.org/10.1007/s13277-015-3491-2
   PubMedGoogle Scholar
• Keizman, D., Ish-Shalom, M., Huang, P., Eisenberger, M. A., Pili, R., Hammers, H., & Carducci, M. A. (2012). The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. European Journal of Cancer, 48(2), 202–208. Oxford, England : 1990. https://doi.org/10.1016/j.ejca.2011.09.001
   PubMed Web of Science ®Google Scholar
• Kessenbrock, K., Plaks, V., & Werb, Z. (2010). Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell, 141(1), 52–67. https://doi.org/10.1016/j.cell.2010.03.015
   PubMed Web of Science ®Google Scholar
• Khan, S., Khan, S. A., Luo, X., Fattah, F. J., Saltarski, J., Gloria McCutchen, Y., Lu, R., Xie, Y., Li, Q., Wakeland, E., & Gerber, D. E. (2019). Immune dysregulation in cancer patients developing immune-related adverse events. British Journal of Cancer, 120(1), 63–68. https://doi.org/10.1038/s41416-018-0155-1
   PubMed Web of Science ®Google Scholar
• Khoo, H. E., Azlan, A., Kong, K. W., & Ismail, A. (2016). Phytochemicals and medicinal properties of indigenous tropical fruits with potential for commercial development. Evidence-Based Complementary and Alternative Medicine: eCam, 2016, 7591951. https://doi.org/10.1155/2016/7591951
   PubMed Web of Science ®Google Scholar
• Kim, T. J., Cho, K. S., & Koo, K. C. (2020). Current status and future perspectives of immunotherapy for locally advanced or metastatic urothelial carcinoma: A comprehensive review. Cancers, 12(1), 192. https://doi.org/10.3390/cancers12010192
   PubMed Web of Science ®Google Scholar
• Kitamura, T., Qian, B. Z., & Pollard, J. W. (2015). Immune cell promotion of metastasis. Nature reviews Immunology, 15(2), 73–86. https://doi.org/10.1038/nri3789
   PubMed Web of Science ®Google Scholar
• Kolaczkowska, E., & Kubes, P. (2013). Neutrophil recruitment and function in health and inflammation. Nature Reviews Immunology, 13(3), 159–175. https://doi.org/10.1038/nri3399
   PubMed Web of Science ®Google Scholar
• Kucerova, P., & Cervinkova, M. (2016). Spontaneous regression of tumour and the role of microbial infection–possibilities for cancer treatment. Anti-cancer drugs, 27(4), 269–277. https://doi.org/10.1097/CAD.0000000000000337
   PubMed Web of Science ®Google Scholar
• Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016). The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends in Immunology, 37(3), 208–220. https://doi.org/10.1016/j.it.2016.01.004
   PubMed Web of Science ®Google Scholar
• Kumar, A., Swain, C. A., & Shevde, L. A. (2021). Informing the new developments and future of cancer immunotherapy : Future of cancer immunotherapy. Cancer Metastasis Reviews, 40(2), 549–562. https://doi.org/10.1007/s10555-021-09967-1
   PubMed Web of Science ®Google Scholar
• Lanier, L. L. (2005). Missing self, NK cells, and the White Album. Journal of Immunology, 174(11), 6565. Baltimore, Md.: 1950. https://doi.org/10.4049/jimmunol.174.11.6565
   PubMed Web of Science ®Google Scholar
• Lee, S. J., Chinen, J., & Kavanaugh, A. (2010). Immunomodulator therapy: Monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins. The Journal of Allergy and Clinical Immunology, 125(2 Suppl 2), S314–323. https://doi.org/10.1016/j.jaci.2009.08.018
   PubMed Web of Science ®Google Scholar
• Lee, W. H., Loo, C. Y., Bebawy, M., Luk, F., Mason, R. S., & Rohanizadeh, R. (2013). Curcumin and its derivatives:Their application in neuropharmacology and neuroscience in the 21st century. Current neuropharmacology, 11(4), 338–378. https://doi.org/10.2174/1570159X11311040002
   PubMed Web of Science ®Google Scholar
• Le Mercier, I., Lines, J. L., & Noelle, R. J. (2015). Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators. Frontiers in Immunology, 6, 418. https://doi.org/10.3389/fimmu.2015.00418
   PubMed Web of Science ®Google Scholar
• Lim, S. Y., Lee, J. H., Gide, T. N., Menzies, A. M., Guminski, A., Carlino, M. S., Breen, E. J., Yang, J., Ghazanfar, S., Kefford, R. F., Scolyer, R. A., Long, G. V., & Rizos, H. (2019). Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1-Based Immunotherapy. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 25(5), 1557–1563. https://doi.org/10.1158/1078-0432.CCR-18-2795
   PubMed Web of Science ®Google Scholar
• Liu, R. B., Engels, B., Arina, A., Schreiber, K., Hyjek, E., Schietinger, A., Binder, D. C., Butz, E., Krausz, T., Rowley, D. A., Jabri, B., & Schreiber, H. (2012). Densely granulated murine NK cells eradicate large solid tumors. Cancer Research, 72(8), 1964–1974. https://doi.org/10.1158/0008-5472.CAN-11-3208
   PubMed Web of Science ®Google Scholar
• Liu, Y., Zhou, X., Liu, X., & Jiang, X. (2021). The immunology and immunotherapy for COVID-19. Expert reviews in molecular medicine, 23(e24), 1–13. https://doi.org/10.1017/erm.2021.30
   Web of Science ®Google Scholar
• López-Jornet, P., Camacho-Alonso, F., & Salazar-Sanchez, N. (2010). Topical tacrolimus and pimecrolimus in the treatment of oral lichen planus: An update. Journal of Oral Pathology & Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 39(3), 201–205. https://doi.org/10.1111/j.1600-0714.2009.00830.x
   PubMed Web of Science ®Google Scholar
• Mahoney, K. M., Ross Macdonald, P., Yuan, L., Song, L., Veras, E., Wind-Rotolo, M., McDermott, D. F., Stephen Hodi, F., Choueiri, T. K., & Freeman, G. J. (2022). Soluble PD-L1 as an early marker of progressive disease on nivolumab. Journal for Immunotherapy of Cancer, 10(2), e003527. https://doi.org/10.1136/jitc-2021-003527
   PubMed Web of Science ®Google Scholar
• Maker, A. V., Phan, G. Q., Attia, P., Yang, J. C., Sherry, R. M., Topalian, S. L., Kammula, U. S., Royal, R. E., Haworth, L. R., Levy, C., Kleiner, D., Mavroukakis, S. A., Yellin, M., & Rosenberg, S. A. (2005). Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: A phase I/II study. Annals of Surgical Oncology, 12(12), 1005–1016. https://doi.org/10.1245/ASO.2005.03.536
   PubMed Web of Science ®Google Scholar
• Mandal, R., & Chan, T. A. (2016). Personalized oncology meets immunology: The path toward precision immunotherapy. Cancer Discovery, 6(7), 703–713. https://doi.org/10.1158/2159-8290.CD-16-0146
   PubMed Web of Science ®Google Scholar
• Mangsbo, S. M., Sandin, L. C., Anger, K., Korman, A. J., Loskog, A., & Tötterman, T. H. (2010). Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy. Journal of Immunotherapy, 33(3), 225–235. Hagerstown, Md. : 1997. https://doi.org/10.1097/CJI.0b013e3181c01fcb
   PubMed Web of Science ®Google Scholar
• Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017). Tumour-associated macrophages as treatment targets in oncology. Nature Reviews Clinical Oncology, 14(7), 399–416. https://doi.org/10.1038/nrclinonc.2016.217
   PubMed Web of Science ®Google Scholar
• Marcus, A., Gowen, B. G., Thompson, T. W., Iannello, A., Ardolino, M., Deng, W., Wang, L., Shifrin, N., & Raulet, D. H. (2014). Recognition of tumors by the innate immune system and natural killer cells. Advances in Immunology, 122, 91–128. https://doi.org/10.1016/B978-0-12-800267-4.00003-1
   PubMed Web of Science ®Google Scholar
• Martin, A. D., Wang, X., Sandberg, M. L., Negri, K. R., Wu, M. L., Toledo Warshaviak, D., Gabrelow, G. B., McElvain, M. E., Lee, B., Daris, M. E., Xu, H., & Kamb, A. (2021). Re-examination of MAGE-A3 as a T-cell Therapeutic Target. Journal of Immunotherapy, 44(3), 95–105. Hagerstown, Md. : 1997. https://doi.org/10.1097/CJI.0000000000000348
   PubMed Web of Science ®Google Scholar
• Massague, J. (2008). Tgfbeta in Cancer. Cell, 134(2), 215–230. https://doi.org/10.1016/j.cell.2008.07.001
   PubMed Web of Science ®Google Scholar
• Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., Manne, S., Chen, Z., Huang, Y. J., Reilly, J. P., Weisman, A. R., Ittner, C., Kuthuru, O., Dougherty, J., Nzingha, K. … Wherry, E. J. (2020). Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science, 369(6508), eabc8511. New York, N.Y. https://doi.org/10.1126/science.abc8511
   PubMed Web of Science ®Google Scholar
• McAllister, S. S., & Weinberg, R. A. (2014). The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nature Cell Biology, 16(8), 717–727. https://doi.org/10.1038/ncb3015
   PubMed Web of Science ®Google Scholar
• Miliotou, A. N., & Papadopoulou, L. C. (2018). CAR T-cell Therapy: A new era in cancer immunotherapy. Current Pharmaceutical Biotechnology, 19(1), 5–18. https://doi.org/10.2174/1389201019666180418095526
   PubMed Web of Science ®Google Scholar
• Mirabile, A., Brioschi, E., Ducceschi, M., Piva, S., Lazzari, C., Bulotta, A., Viganò, M. G., Petrella, G., Gianni, L., & Gregorc, V. (2019). PD-1 inhibitors-related neurological toxicities in patients with non-small-cell lung cancer: A literature review. Cancers, 11(3), 296. https://doi.org/10.3390/cancers11030296
   PubMed Web of Science ®Google Scholar
• Moghadamtousi, S. Z., Kadir, H. A., Hassandarvish, P., Tajik, H., Abubakar, S., & Zandi, K. (2014). A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Research International, 2014, 186864. https://doi.org/10.1155/2014/186864
   PubMed Web of Science ®Google Scholar
• Mukherjee, P., Nema, N., Bhadra, S., Mukherjee, D., Braga, F., & Matsabisa, M. (2014). Immunomodulatory leads from medicinal plants. Indian Journal of Traditional Knowledge, 13(2), 235–256. http://nopr.niscair.res.in/bitstream/123456789/27905/1/IJTK%20132%20235-256.pdf
   Web of Science ®Google Scholar
• Muñoz-Rivas, N., Abad Motos, A., Mestre-Gómez, B., Sierra-Hidalgo, F., Cortina-Camarero, C., Lorente-Ramos, R. M., Torres-Rubio, P., Arranz-García, P., Franco-Moreno, A. I., Gómez-Mariscal, E., Mauleón-Fernández, C., Alonso-García, S., Rogado, J., Saez-Vaquero, T., Such Diaz, A., Ryan, P., Moya-Mateo, E., Martín-Navarro, J. A., Hernández-Rivas, J. A., & Torres Macho, J. (2021). Ystemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study. Thrombosis Research, 199, 132–142. … Infanta Leonor Thrombosis Research Group. https://doi.org/10.1016/j.thromres.2020.12.024
   PubMed Web of Science ®Google Scholar
• Naidoo, J., Page, D. B., & Wolchok, J. D. (2014). Immune modulation for cancer therapy. British Journal of Cancer, 111(12), 2214–2219. https://doi.org/10.1038/bjc.2014.348
   PubMed Web of Science ®Google Scholar
• Naidoo, J., Wang, X., Woo, K. M., Iyriboz, T., Halpenny, D., Cunningham, J., Chaft, J. E., Segal, N. H., Callahan, M. K., Lesokhin, A. M., Rosenberg, J., Voss, M. H., Rudin, C. M., Rizvi, H., Hou, X., Rodriguez, K., Albano, M., Gordon, R. A., Leduc, C. … Hellmann, M. D. (2017). Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 35(7), 709–717. https://doi.org/10.1200/JCO.2016.68.2005
   PubMed Web of Science ®Google Scholar
• Noy, R., & Pollard, J. W. (2014). Tumor-associated macrophages: From mechanisms to therapy. Immunity, 41(1), 49–61. https://doi.org/10.1016/j.immuni.2014.06.010
   PubMed Web of Science ®Google Scholar
• O’Day, S. J., Hamid, O., & Urba, W. J. (2007). Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): A novel strategy for the treatment of melanoma and other malignancies. Cancer, 110(12), 2614–2627. https://doi.org/10.1002/cncr.23086
   PubMed Web of Science ®Google Scholar
• O’Donnell, J. S., Long, G. V., Scolyer, R. A., Teng, M. W., & Smyth, M. J. (2017). Resistance to PD1/PDL1 checkpoint inhibition. Cancer Treatment Reviews, 52, 71–81. https://doi.org/10.1016/j.ctrv.2016.11.007
   PubMed Web of Science ®Google Scholar
• Oh, D. Y., Cham, J., Zhang, L., Fong, G., Kwek, S. S., Klinger, M., Faham, M., & Fong, L. (2017). Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients are Associated with Early Diversification of the T-cell Repertoire. Cancer Research, 77(6), 1322–1330. https://doi.org/10.1158/0008-5472.CAN-16-2324
   PubMed Web of Science ®Google Scholar
• Ott, P. A. *, Stephen Hodi, F., Kaufman, H. L., Wigginton, J. M. and Wolchok, J. D. (2017). Combination immunotherapy: A road map. Journal for Immunotherapy of Cancer, 5(1), 16. *. https://doi.org/10.1186/s40425-017-0218-5
   PubMed Web of Science ®Google Scholar
• Pabla, N., & Dong, Z. (2012). Curtailing side effects in chemotherapy: A tale of PKCδ in cisplatin treatment. Oncotarget, 3(1), 107–111. https://doi.org/10.18632/oncotarget.439
   PubMed Web of Science ®Google Scholar
• Parvu, A. E., Parvu, M., Vlase, L., Miclea, P., Mot, A. C., & Silaghi Dumitrescu, R. (2014). Anti-inflammatory effects of Allium schoenoprasum L. leaves. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society, 65(2), 309–315. https://pubmed.ncbi.nlm.nih.gov/24781739/
   PubMed Web of Science ®Google Scholar
• Perkins, D., Wang, Z., Donovan, C., He, H., Mark, D., Guan, G., Wang, Y., Walunas, T., Bluestone, J., Listman, J., & Finn, P. W. (1996). Regulation of CTLA-4 expression during T cell activation. Journal of Immunology, 156(11), 4154–4159. Baltimore, Md. : 1950. https://pubmed.ncbi.nlm.nih.gov/8666782/.
   PubMed Web of Science ®Google Scholar
• Pijpe, J., Meijer, J. M., Bootsma, H., van der Wal, J. E., Spijkervet, F. K., Kallenberg, C. G., Vissink, A., & Ihrler, S. (2009). Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren’s syndrome. Arthritis and Rheumatism, 60(11), 3251–3256. https://doi.org/10.1002/art.24903
   PubMed Web of Science ®Google Scholar
• Qian, B. Z., Zhang, H., Li, J., He, T., Yeo, E. J., Soong, D. Y., Carragher, N. O., Munro, A., Chang, A., Bresnick, A. R., Lang, R. A., & Pollard, J. W. (2015). FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis. The Journal of Experimental Medicine, 212(9), 1433–1448. https://doi.org/10.1084/jem.20141555
   PubMed Web of Science ®Google Scholar
• Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature medicine, 19(11), 1423–1437. https://doi.org/10.1038/nm.3394
   PubMed Web of Science ®Google Scholar
• Rezaei, N., Aalaei-Andabili, S. H., Amini, N., Delavari, F., Keshavarz-Fathi, M., & Kaufman, H. L. (2020). Introduction on Cancer Immunology and Immunotherapy. In N. Rezaei (Ed.), Cancer Immunology. Springer. https://doi.org/10.1007/978-3-030-30845-2_1
   Google Scholar
• Richeldi, L., Costabel, U., Selman, M., Kim, D. S., Hansell, D. M., Nicholson, A. G., Brown, K. K., Flaherty, K. R., Noble, P. W., Raghu, G., Brun, M., Gupta, A., Juhel, N., Klüglich, M., & du Bois, R. M. (2011). Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. The New England Journal of Medicine, 365(12), 1079–1087. https://doi.org/10.1056/NEJMoa1103690
   PubMed Web of Science ®Google Scholar
• Richeldi, L., Kolb, M., Jouneau, S., Wuyts, W. A., Schinzel, B., Stowasser, S., Quaresma, M., & Raghu, G. (2020). Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis. BMC Pulmonary Medicine, 20(1), 3. https://doi.org/10.1186/s12890-019-1030-4
   PubMed Web of Science ®Google Scholar
• Rosenberg, S. A. (2014). Decade in review-cancer immunotherapy: Entering the mainstream of cancer treatment. Nature Reviews Clinical Oncology, 11(11), 630–632. https://doi.org/10.1038/nrclinonc.2014.174
   PubMed Web of Science ®Google Scholar
• Rungkat, F.-Z., Nurahman, N., Prangdimurt, E. P., & Tejasari, T. (2003). Antioxidant and immune enhancement activities of ginger (zingiber officinale roscoe) extracts and compounds in in vitro and in vivo mouse and human system. Preventive Nutrition and Food Science, 8(1), 96–104. https://doi.org/10.3746/jfn.2003.8.1.096
   Google Scholar
• Salto-Tellez, M., Tan, E., & Lim, B. (2005). ARDS in SARS: Cytokine mediators and treatment implications. Cytokine, 29(2), 92–94. https://doi.org/10.1016/j.cyto.2004.09.002
   PubMed Web of Science ®Google Scholar
• Schonder, K. S., Mazariegos, G. V., & Weber, R. J. (2010). Adverse effects of immunosuppression in pediatric solid organ transplantation. Paediatric drugs, 12(1), 35–49. https://doi.org/10.2165/11316180-000000000-00000
   PubMedGoogle Scholar
• Schumacher, T. N., & Schreiber, R. D. (2015). Neoantigens in cancer immunotherapy. Science, 348(6230), 69–74. New York, N.Y. https://doi.org/10.1126/science.aaa4971
   PubMed Web of Science ®Google Scholar
• Shankar-Hari, M., Spencer, J., Sewell, W. A., Rowan, K. M., & Singer, M. (2012). Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective. Critical care Critical care, 16(2), 206. London, England. https://doi.org/10.1186/cc10597
   PubMed Web of Science ®Google Scholar
• Siddiqi, H. K., & Mehra, M. R. (2020). COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, 39(5), 405–407. https://doi.org/10.1016/j.healun.2020.03.012
   PubMed Web of Science ®Google Scholar
• Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 66(1), 7–30. https://doi.org/10.3322/caac.21332
   PubMed Web of Science ®Google Scholar
• Smyth, M. J., Ngiow, S. F., Ribas, A., & Teng, M. W. (2016). Combination cancer immunotherapies tailored to the tumour microenvironment. Nature Reviews Clinical Oncology, 13(3), 143–158. https://doi.org/10.1038/nrclinonc.2015.209
   PubMed Web of Science ®Google Scholar
• Speiser, D. E., Ho, P. C., & Verdeil, G. (2016). Regulatory circuits of T cell function in cancer. Nature Reviews Immunology, 16(10), 599–611. https://doi.org/10.1038/nri.2016.80
   PubMed Web of Science ®Google Scholar
• Subudhi, S. K., Aparicio, A., Gao, J., Zurita, A. J., Araujo, J. C., Logothetis, C. J., Tahir, S. A., Korivi, B. R., Slack, R. S., Vence, L., Emerson, R. O., Yusko, E., Vignali, M., Robins, H. S., Sun, J., Allison, J. P., & Sharma, P. (2016). Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities. Proceedings of the National Academy of Sciences of the United States of America, 113(42), 11919–11924. https://doi.org/10.1073/pnas.1611421113
   PubMed Web of Science ®Google Scholar
• Syabana, M. A., Yuliana, N. D., Batubara, I., & Fardiaz, D. (2020). Antidiabetic activity screening and NMR profile of vegetable and spices commonly consumed in Indonesia. Food Science and Technology, 41(suppl 1), 254–264. https://doi.org/10.1590/fst.14120
   Web of Science ®Google Scholar
• Talasaz, A. H., Sadeghipour, P., Kakavand, H., Aghakouchakzadeh, M., Kordzadeh-Kermani, E., Van Tassell, B. W., Gheymati, A., Ariannejad, H., Hosseini, S. H., Jamalkhani, S., Sholzberg, M., Monreal, M., Jimenez, D., Piazza, G., Parikh, S. A., Kirtane, A. J., Eikelboom, J. W., Connors, J. M., Hunt, B. J. … Bikdeli, B. (2021). Recent randomized trials of antithrombotic therapy for patients with COVID-19: Jacc state-of-the-art review. Journal of the American College of Cardiology, 77(15), 1903–1921. https://doi.org/10.1016/j.jacc.2021.02.035
   PubMed Web of Science ®Google Scholar
• Tanaka, A., & Sakaguchi, S. (2017). Regulatory T cells in cancer immunotherapy. Cell Research, 27(1), 109–118. https://doi.org/10.1038/cr.2016.151
   PubMed Web of Science ®Google Scholar
• Taube, J. M., Klein, A., Brahmer, J. R., Xu, H., Pan, X., Kim, J. H., Chen, L., Pardoll, D. M., Topalian, S. L., & Anders, R. A. (2014). Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 20(19), 5064–5074. https://doi.org/10.1158/1078-0432.CCR-13-3271
   PubMed Web of Science ®Google Scholar
• Teft, W. A., Kirchhof, M. G., & Madrenas, J. (2006). A molecular perspective of CTLA-4 function. Annual Review of Immunology, 24(1), 65–97. https://doi.org/10.1146/annurev.immunol.24.021605.090535
   PubMed Web of Science ®Google Scholar
• Teng, M. W., Galon, J., Fridman, W. H., & Smyth, M. J. (2015). From mice to humans: Developments in cancer immunoediting. The Journal of Clinical Investigation, 125(9), 3338–3346. https://doi.org/10.1172/JCI80004
   PubMed Web of Science ®Google Scholar
• Thomas, L. (1959) Discussion. In H. Lawrence, Ed. Cellular and Humoral Aspects of the Hypersensitive States. Hoeber-Harper; pp. 529–532. 1959. https://www.scirp.org/Si43dyn45teexjx455qlt3d2q/reference/ReferencesPapers.aspx?ReferenceID=865233
   Google Scholar
• Tian, Y., Zhang, Z., Yang, X., Li, D., Zhang, L., Li, Z., Zhang, S., Mao, Y., Jin, C., & Zhao, Y. (2020). The risk ratio of immune-related colitis, hepatitis, and pancreatitis in patients with solid tumors caused by pd-1/pd-l1 inhibitors: A systematic review and meta-analysis. Frontiers in Oncology, 10, 261. https://doi.org/10.3389/fonc.2020.00261
   PubMed Web of Science ®Google Scholar
• Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015). Immune checkpoint blockade: A common denominator approach to cancer therapy. Cancer cell, 27(4), 450–461. https://doi.org/10.1016/j.ccell.2015.03.001
   PubMed Web of Science ®Google Scholar
• van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254(5038), 1643–1647. New York, N.Y. https://doi.org/10.1126/science.1840703
   PubMed Web of Science ®Google Scholar
• Ventola, C. L. (2017). Cancer Immunotherapy, Part 3: Challenges and Future Trends. P & T : A Peer-Reviewed Journal for Formulary Management, 42(8), 514–521.C. https://pubmed.ncbi.nlm.nih.gov/28781505/
   PubMedGoogle Scholar
• Voskoboinik, I., Smyth, M. J., & Trapani, J. A. (2006). Perforin-mediated target-cell death and immune homeostasis. Nature Reviews Immunology, 6(12), 940–952. https://doi.org/10.1038/nri1983
   PubMed Web of Science ®Google Scholar
• Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M. S., Vitale, M., Bottino, C., Moretta, L., Moretta, A., & Long, E. O. (1995). Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity, 2(5), 439–449. https://doi.org/10.1016/1074-7613(95)90025-x
   PubMed Web of Science ®Google Scholar
• Wang-Gillam, A., Plambeck-Suess, S., Goedegebuure, P., Simon, P. O., Mitchem, J. B., Hornick, J. R., Sorscher, S., Picus, J., Suresh, R., Lockhart, A. C., Tan, B., & Hawkins, W. G. (2013). A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma. Investigational New Drugs, 31(3), 707–713. https://doi.org/10.1007/s10637-012-9866-y
   PubMed Web of Science ®Google Scholar
• Wang, Y., Wang, M., Wu, H. X., & Xu, R. H. (2021). Advancing to the era of cancer immunotherapy. Cancer Communications, 41(9), 803–829. London, England. https://doi.org/10.1002/cac2.12178
   Web of Science ®Google Scholar
• Wang, X., Zhang, Y., Mu, X., Tu, C. R., Chung, Y., Tsao, S. W., Chan, G. C., Leung, W. H., Lau, Y. L., Liu, Y., & Tu, W. (2022). Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment. Journal for Immunotherapy of Cancer, 10(2), e003832. https://doi.org/10.1136/jitc-2021-003832
   PubMed Web of Science ®Google Scholar
• Ward-Hartstonge, K. A., & Kemp, R. A. (2017). Regulatory T-cell heterogeneity and the cancer immune response. Clinical & translational immunology, 6(9), e154. https://doi.org/10.1038/cti.2017.43
   PubMed Web of Science ®Google Scholar
• Weber, J. S., Hodi, F. S., Wolchok, J. D., Topalian, S. L., Schadendorf, D., Larkin, J., Sznol, M., Long, G. V., Li, H., Waxman, I. M., Jiang, J., & Robert, C. (2017). Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients with Advanced Melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 35(7), 785–792. https://doi.org/10.1200/JCO.2015.66.1389
   PubMed Web of Science ®Google Scholar
• Weidhaas, J., Marco, N., Scheffler, A. W., Kalbasi, A., Wilenius, K., Rietdorf, E., Gill, J., Heilig, M., Desler, C., Chin, R. K., Kaprealian, T., McCloskey, S., Raldow, A., Raja, N. P., Kesari, S., Carrillo, J., Drakaki, A., Scholz, M., & Telesca, D. (2022). Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy. Journal for Immunotherapy of Cancer, 10(2), e003625. https://doi.org/10.1136/jitc-2021-003625
   PubMed Web of Science ®Google Scholar
• Weisberg, E., Parent, A., Yang, P. L., Sattler, M., Liu, Q., Liu, Q., Wang, J., Meng, C., Buhrlage, S. J., Gray, N., & Griffin, J. D. (2020). Repurposing of Kinase Inhibitors for Treatment of COVID-19. Pharmaceutical Research, 37(9). https://doi.org/10.1007/s11095-020-02851-7
   PubMed Web of Science ®Google Scholar
• Weitzenfeld, P., & Ben-Baruch, A. (2014). The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer letters, 352(1), 36–53. https://doi.org/10.1016/j.canlet.2013.10.006
   PubMed Web of Science ®Google Scholar
• West, H. (2014). Nivolumab as first line monotherapy for advanced non-small cell lung cancer: Could we replace first line chemotherapy with immunotherapy? Translational Lung Cancer Research, 3(6), 400–402. https://doi.org/10.3978/j.issn.2218-6751.2014.09.04
   PubMedGoogle Scholar
• Wherry, E. J. (2011). T cell exhaustion. Nature Immunology, 12(6), 492–499. https://doi.org/10.1038/ni.2035
   PubMed Web of Science ®Google Scholar
• Wichers, H. (2009). Immunomodulation by food: Promising concept for mitigating allergic disease? Analytical and Bioanalytical Chemistry, 395(1), 37–45. https://doi.org/10.1007/s00216-009-2838-1
   PubMed Web of Science ®Google Scholar
• Wijaya, I., Andhika, R., Huang, I., Purwiga, A., Budiman, K. Y., Bashari, M. H., Reniarti, L., and Roesli, R. M. A. (2021). The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis. Clinical Epidemiology and Global Health, 11, 100755. https://doi.org/10.1016/j.cegh.2021.100755
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) Coronavirus Disease (COVID-19) Dashboard. Available at https://covid19.who.int/(Accessed on April. 2022)
   Google Scholar
• Wu, D., Lewis, E. D., Pae, M., & Meydani, S. N. (2019). Nutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance. Frontiers in Immunology, 9, 3160. https://doi.org/10.3389/fimmu.2018.03160
   PubMed Web of Science ®Google Scholar
• Xie, G., Dong, H., Liang, Y., Ham, J. D., Rizwan, R., & Chen, J. (2020). CAR-NK cells: A promising cellular immunotherapy for cancer. EBioMedicine, 59, 102975. https://doi.org/10.1016/j.ebiom.2020.102975
   PubMed Web of Science ®Google Scholar
• Xu, K., Cai, H., Shen, Y., Ni, Q., Chen, Y., Hu, S., Li, J., Wang, H., Yu, L., Huang, H., Qiu, Y., Wei, G., Fang, Q., Zhou, J., Sheng, J., Liang, T., & Li, L. (2020). [Management of COVID-19: The Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 49(2), 147–157. https://doi.org/10.3785/j.issn.1008-9292.2020.02.02
   PubMedGoogle Scholar
• Yanai, S., Nakamura, S., & Matsumoto, T. (2017). Nivolumab-Induced Colitis Treated by Infliximab. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 15(4), e80–81. https://doi.org/10.1016/j.cgh.2016.09.017
   PubMed Web of Science ®Google Scholar
• Yang, Y. (2015). Cancer immunotherapy: Harnessing the immune system to battle cancer. The Journal of Clinical Investigation, 125(9), 3335–3337. https://doi.org/10.1172/JCI83871
   PubMed Web of Science ®Google Scholar
• Yang, Y. F., Zou, J. P., Mu, J., Wijesuriya, R., Ono, S., Walunas, T., Bluestone, J., Fujiwara, H., & Hamaoka, T. (1997). Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: The effect is manifested only at the restricted tumor-bearing stages. Cancer Research, 57(18), 4036–4041.
   PubMed Web of Science ®Google Scholar
• Yuliana, N. D., Arifin, A. S., & Rafi, M. (2020). Multiple spectroscopic fingerprinting platforms for rapid characterization of α-glucosidase inhibitors and antioxidants from some commonly consumed Indonesian vegetables and spices. Journal of Food Measurement and Characterization, 14(3), 1699–1707. https://doi.org/10.1007/s11694-020-00418-z
   Web of Science ®Google Scholar
• Yumita, A., Suganda, A. G., & Sukandar, E. Y. (2013). Xanthine oxidase inhibitory activity of some Indonesian medicinal plants and active fraction of selected plants. International Journal of Pharmacy and Pharmaceutical Sciences, 5(2), 293–296. 2013. https://www.researchgate.net/publication/272291788_Xanthine_oxidase_inhibitory_activity_of_some_Indonesian_medicinal_plants_and_active_fraction_of_selected_plants.
   Google Scholar
• Zhai, Z., Liu, Y., Wu, L., Senchina, D. S., Wurtele, E. S., Murphy, P. A., Kohut, M. L., & Cunnick, J. E. (2007). Enhancement of innate and adaptive immune functions by multiple Echinacea species. Journal of Medicinal Food, 10(3), 423–434. https://doi.org/10.1089/jmf.2006.257
   PubMed Web of Science ®Google Scholar
• Zhang, P., Gu, Y., Fang, H., Cao, Y., Wang, J., Liu, H., Zhang, H., Li, H., He, H., Li, R., Lin, C., & Xu, J. (2022). Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer. Journal for Immunotherapy of Cancer, 10(2), e004047. https://doi.org/10.1136/jitc-2021-004047
   PubMed Web of Science ®Google Scholar
• Zhang, Q. W., Liu, L., Gong, C. Y., Shi, H. S., Zeng, Y. H., Wang, X. Z., Zhao, Y. W., & Wei, Y. Q. (2012). Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature. PloS One, 7(12), e50946. https://doi.org/10.1371/journal.pone.0050946
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Yu, L., Tang, L., Zhu, M., Jin, Y., Wang, Z., & Li, L. (2021). A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System. Engineering, 7(1), 11–13. Beijing. https://doi.org/10.1016/j.eng.2020.03.006
   Web of Science ®Google Scholar
• Zhou, N., Li, J., Zhang, Y., Lu, J., Chen, E., Du, W., Wang, J., Pan, X., Zhu, D., Yang, Y., Chen, Y., Cao, H., & Li, L. (2015). Efficacy of coupled low-volume plasma exchange with plasma filtration adsorption in treating pigs with acute liver failure: A randomised study. Journal of Hepatology, 63(2), 378–387. https://doi.org/10.1016/j.jhep.2015.03.018
   PubMed Web of Science ®Google Scholar
• Zugazagoitia, J., Guedes, C., Ponce, S., Ferrer, I., Molina-Pinelo, S., & Paz-Ares, L. (2016). Current Challenges in Cancer Treatment. Clinical Therapeutics, 38(7), 1551–1566. https://doi.org/10.1016/j.clinthera.2016.03.026
   PubMed Web of Science ®Google Scholar